Acute hepatitis induced by greater celandine (Chelidonium majus)

Scandinavian Journal of Gastroenterology

Volumn 38, Issue 5, 2003, Pages 565-568

  Stickel, Felix ^a   Poschl G ^a   Seitz, H K ^a   Waldherr, R ^a   Hahn, E G ^a   Schuppan, D ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Chelidonium majus; Drug induced hepatitis; Greater Celandine; Hepatotoxicity; Herbal drugs

Indexed keywords

CHELIDONIUM EXTRACT;

ACUTE HEPATITIS; ADULT; AGED; ARTICLE; CASE REPORT; CHELIDONIUM; CHOLESTATIC HEPATITIS; CLINICAL FEATURE; DATA BASE; DISEASE COURSE; DRUG APPROVAL; DRUG SCREENING; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; IRRITABLE COLON; LABORATORY TEST; LIVER INJURY; MALE; PRIORITY JOURNAL; RECURRENT DISEASE;

ADULT; AGED; CHELIDONIUM; CHOLESTASIS; FEMALE; HEPATITIS, TOXIC; HUMANS; MALE; MEDICINE, HERBAL;

EID: 0037951288     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365520310000942     Document Type: Article

References (17)

1. Kessler RC, Davies RB, Foster DF, Van Rompay MI, Walters EE, Wilkey SA, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001;135:262-8.
2. Ernst E. The risk - benefit profile of commonly used herbal therapies: gingko, St. John's wort, ginseng, echinacea, saw palmetto, and Kava. Ann Intern Med 2002;136:42-53.
3. Stickel F, Seitz HK. The efficacy and safety of comfrey. Pub Health Nutr 2000;3(4A):501-8.
4. Ridker PM, Ohkuma S, McDermott WV, Trey C, Huxtable RJ. Hepatic venoocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology 1985;88:1050-4.
5. Larrey D, Vial T, Pauwels A, Castot A, Biour M, David M, et al. Hepatitis after Germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med 1992;117:129-32.
6. Yoshida EM, McLean CA, Cheng ES, Blanc PD, Somberg KA, Ferrell LD, et al. Chinese herbal medicine, fulminant hepatitis, and liver transplantation. Am J Gastroenterol 1996;91:2647-8.
7. Ernst E. Safety concerns about kava. Lancet 2002;359:1865.
8. Kraft M, Spahn TW, Menzel J, Senninger N, Dietl KH, Herbst H, et al. Fulminant liver failure after administration of the herbal antidepressant Kava-Kava [in German]. Dtsch Med Wschr 2001;126:970-2.
9. Benninger J, Schneider HT, Schuppan D, Kirchner T, Hahn EG. Acute hepatitis induced by greater celandine (Chelidonium majus). Gastroenterology 1999;117:1234-7.
10. Report of an International Consensus Meeting., Criteria of drug-induced liver disorders. J Hepatol 1990;11:272-6.
11. Maria VAJ, Victorino RMM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997;26:664-9.
12. Lucena MI, Camargo R, Andrade RJ, Perez-Sanchez CJ, De la Cuesta FS. Comparison of two clinical scales for causality assessment in hepatotoxicity. Hepatology 2001;33:123-30.
13. Colombo ML, Bosisio E. Pharmacological activities of Chelidonium majus L. (Papaveraceae). Pharmacol Res 1996;33:127-34.
14. Vahensieck U, Hahn R, Winterhoff H, Gumbinger HG, Nahrsted A, Kemper FH. The effect of Chelidonium majus herb extract on choleresis in the isolated perfused rat liver. Planta Med 1992;58:35-8.
15. Strahl S, Ehret V, Dahm HH, Maier KP. Necrotizing hepatitis after taking herbal medication extracts of kava or of common or lesser celandine [in German]. Dtsch Med Wochenschr 1998;123:1410-4.
16. Greving I, Meister V, Monnerjahn C, Müller KM, May B. Chelidonium majus: a rare reason for severe hepatotoxic reaction. Pharmaepidemiol Drug Safety 1998;7:S66-9.
17. Crijns AP, de Smet PA, van den Heuvel M, Schot BW, Haagsma EB. Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus) (in Dutch]. Ned Tijdschr Geneeskd 2002;146:124-8.